ClinicalTrials.govpublic full text
First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer
prostatic neoplasms, phase i, dose escalation, prostate cancer, antibodies, bispecific t-cell engager (bite), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862073
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.